A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP

NCT03988920 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia
End Stage Renal Disease

Interventions

DRUG: Tenapanor
DRUG: Sevelamer Carbonate

Sponsor

Ardelyx